Clinical Trials Browser

Phase 3 × OTHER × Injections, Subcutaneous × Clear all

NCT06505837 2025-08-28

JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）

Phase 3 Active not recruiting

Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer

NCT02927379 2018-01-09

Effect of Wound Infiltration by Ketamine Versus Dexmedetomidine Added to Bupivacaine on Surgical Stress

Phase 3 Completed

Abdominal Cancer